Literature DB >> 15065204

Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection.

Thomas Albrecht1, Cheng Zong Deng, Sherif Z Abdel-Rahman, Michael Fons, Paul Cinciripini, Randa A El-Zein.   

Abstract

We used the mutagen sensitivity assay to test the hypothesis that human cytomegalovirus (HCMV) infection modifies the sensitivity of cells to genetic damage from genotoxic agents. Chromosome aberration (CA) frequency in peripheral blood lymphocytes (PBLs) from 20 smokers who were matched with 20 nonsmokers by age (+/- 5 years), sex, and ethnicity was evaluated following in vitro exposure to bleomycin and/or HCMV infection. Bleomycin induced significant (P < 0.05) concentration-dependent increases in the frequency of aberrant cells, chromatid-type damage (breaks), and chromosome-type aberrations (deletions, rearrangements) in PBLs. The baseline (background) CA frequency was similar in both smokers and nonsmokers. Significantly higher frequencies of aberrant cells (P < 0.05) were observed in PBLs from smokers compared to nonsmokers at all bleomycin concentrations tested (10, 30 and 100 microg/ml). Infection of PBLs with HCMV induced a significant (P < 0.05) twofold increase in the frequency of CA (primarily chromatid breaks) in PBLs, regardless of the smoking status. PBLs from smokers and nonsmokers infected with HCMV prior to challenge with bleomycin demonstrated significant (P < 0.05) concentration-dependent increases in the levels of aberrant cells, chromatid-type damage (breaks), and chromosome-type aberrations (deletions, rearrangements) compared to noninfected cells challenged with bleomycin. The frequency of induced CA was consistently higher for PBLs derived from smokers relative to nonsmokers (P = 0.06 and 0.002). These data indicate that, individually, both smoking and HCMV infection significantly enhance the sensitivity of PBLs to bleomycin-induced genetic damage. More importantly, the data also suggest that smoking and HCMV infection interact synergistically to enhance the sensitivity of PBLs to such damage. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065204     DOI: 10.1002/em.20012

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  6 in total

Review 1.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

2.  Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes.

Authors:  Li Jiao; Ping Chang; Pervez F Firozi; Dejian Lai; James L Abbruzzese; Donghui Li
Journal:  Mutat Res       Date:  2006-12-08       Impact factor: 2.433

3.  Detection of human cytomegalovirus in different histological types of gliomas.

Authors:  Michael E Scheurer; Melissa L Bondy; Kenneth D Aldape; Thomas Albrecht; Randa El-Zein
Journal:  Acta Neuropathol       Date:  2008-03-20       Impact factor: 17.088

4.  Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis.

Authors:  Allison E Aiello; Ana Diez-Roux; Anne-Michelle Noone; Nalini Ranjit; Mary Cushman; Michael Y Tsai; Moyses Szklo
Journal:  Brain Behav Immun       Date:  2008-12-25       Impact factor: 7.217

Review 5.  DNA repair mechanisms and human cytomegalovirus (HCMV) infection.

Authors:  Beata Smolarz; Jan Wilczyński; Dorota Nowakowska
Journal:  Folia Microbiol (Praha)       Date:  2014-11-01       Impact factor: 2.099

6.  Modulation of Radiation-Induced Genetic Damage by HCMV in Peripheral Blood Lymphocytes from a Brain Tumor Case-Control Study.

Authors:  Elizabeth A Rourke; Mirtha S Lopez; Claudia M Monroy; Michael E Scheurer; Carol J Etzel; Thomas Albrecht; Melissa L Bondy; Randa A El-Zein
Journal:  Cancers (Basel)       Date:  2010-04-12       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.